IVCR.Q Stock Overview
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Invacare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.013 |
| 52 Week High | US$1.64 |
| 52 Week Low | US$0.011 |
| Beta | 0.51 |
| 1 Month Change | -10.00% |
| 3 Month Change | -62.60% |
| 1 Year Change | -99.09% |
| 3 Year Change | -99.77% |
| 5 Year Change | -99.92% |
| Change since IPO | -99.49% |
Recent News & Updates
Recent updates
Invacare falls on bankruptcy filing
Feb 01Invacare announces additional draw of $5.5M term loans
Dec 27Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates
Nov 14
Invacare GAAP EPS of -$0.92, revenue of $170.4M
Nov 07Invacare receives non-compliance letter from NYSE
Sep 29Invacare names Geoffrey Purtill as interim president and executive chief
Aug 29Invacare adds two new directors after deal with largest investor Azurite
Aug 23Returns Are Gaining Momentum At Invacare (NYSE:IVC)
Apr 30Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky
Jan 27Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
Dec 01Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load
Sep 30When Should You Buy Invacare Corporation (NYSE:IVC)?
Aug 06Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)
May 14Invacare EPS misses by $0.02, misses on revenue
May 05Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)
May 03Invacare Corporation's (NYSE:IVC) Path To Profitability
Mar 03Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet
Feb 05
What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?
Jan 10Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.
Dec 14Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit
Nov 23Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation
Oct 30Shareholder Returns
| IVCR.Q | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -10.6% | -4.4% | -3.7% |
| 1Y | -99.1% | -2.8% | 20.2% |
Return vs Industry: IVCR.Q underperformed the US Medical Equipment industry which returned -1.8% over the past year.
Return vs Market: IVCR.Q underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| IVCR.Q volatility | |
|---|---|
| IVCR.Q Average Weekly Movement | 28.2% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IVCR.Q's share price has been volatile over the past 3 months.
Volatility Over Time: IVCR.Q's weekly volatility (28%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1885 | 2,800 | Geoff Purtill | www.invacare.com |
Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the Pin Dot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products.
Invacare Corporation Fundamentals Summary
| IVCR.Q fundamental statistics | |
|---|---|
| Market cap | US$512.81k |
| Earnings (TTM) | -US$101.07m |
| Revenue (TTM) | US$741.73m |
0.0x
P/S Ratio0.0x
P/E RatioIs IVCR.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IVCR.Q income statement (TTM) | |
|---|---|
| Revenue | US$741.73m |
| Cost of Revenue | US$557.69m |
| Gross Profit | US$184.04m |
| Other Expenses | US$285.12m |
| Earnings | -US$101.07m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.66 |
| Gross Margin | 24.81% |
| Net Profit Margin | -13.63% |
| Debt/Equity Ratio | 436.8% |
How did IVCR.Q perform over the long term?
See historical performance and comparison